Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+) cells. (Q52013233)
Jump to navigation
Jump to search
scientific article published in May 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+) cells. |
scientific article published in May 2002 |
Statements
1 reference
Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+) cells. (English)
1 reference
Antonio J da Silva
1 reference
Margot Brickelmaier
1 reference
Gerard R Majeau
1 reference
Zhifang Li
1 reference
Lihe Su
1 reference
Yen-Ming Hsu
1 reference
Paula S Hochman
1 reference
1 May 2002
1 reference
1 reference
168
1 reference
4462-4471
1 reference
9
1 reference
Identifiers
1 reference